Eli Lilly to Invest $6.5 Billion in Houston for New Pharmaceutical Manufacturing Campus
TL;DR Summary
Eli Lilly plans to invest $6.5 billion to build a new pharmaceutical manufacturing facility in Houston, Texas, creating over 4,600 jobs and focusing on small molecule medicines, including Lilly's first oral GLP-1 receptor agonist, to enhance domestic production and innovation.
- Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Texas Eli Lilly and Company
- Eli Lilly announces plans for $6.5B manufacturing plant in Houston KHOU
- Eli Lilly to build $6.5 billion Texas manufacturing facility for obesity pill, other drugs CNBC
- Eli Lilly to Build $6.5 Billion Texas Facility to Boost U.S. Ingredient Manufacturing The Wall Street Journal
- Eli Lilly announces $6.5 billion manufacturing campus in Houston Click2Houston
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
6 min
vs 6 min read
Condensed
97%
1,157 → 40 words
Want the full story? Read the original article
Read on Eli Lilly and Company